A new study uncovered an association between exposure to chemicals commonly used in firefighting and glioma risk, reinforcing earlier research that has suggested a link between firefighting and the development of cancers.

The small study led by Dr. Elizabeth B. Claus, a professor at the Yale School of Public Health, member of Yale Cancer Center, and founder of the International Low Grade Glioma Registry, showed that the glioma tumors of some firefighters had a distinctive genetic pattern or “mutational signature.” Those specific signatures were previously shown to be caused by exposure to chemicals called haloalkanes, which are associated with flame retardants, fire extinguishants, and propellants. The study results were published March 10 in Cancer, a peer-reviewed journal of the American Cancer Society.

A novel analysis of more than 375 published studies concluded that the association between chronic pain and rates of depression and anxiety is staggering. The study, led by investigators at Johns Hopkins Medicine found that 40% of adults with chronic pain experienced “clinically significant depression and anxiety.” Among those most at risk, the analysis showed, were women, younger adults and people with fibromyalgia.

The treatment of Helicobacter pylori (H. pylori) infection remains a challenge due to the increasing prevalence of drug-resistant bacteria. It is hypothesized that using more potent acid suppressants, such as potassium-competitive acid blockers (P-CABs) like Vonoprazan, may improve eradication rates. The aim of this study was to compare the effectiveness of H. pylori eradication regimens containing Vonoprazan with those containing proton pump inhibitors for H. pylori infection.

A new study led by researchers from Boston University Chobanian & Avedisian School of Medicine have discovered key risk factors that can help predict when surgery for gallbladder cancer may not be beneficial, leading to ER or complications.